Mazumder A - Search Results

1

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies.

Hu E, Epstein AL, Naeve GS, Gill I, Martin S, Sherrod A, Nichols P, Chen D, Mazumder A, Levine AM. Hu E, et al. Among authors: mazumder a. Hematol Oncol. 1989 Mar-Apr;7(2):155-66. doi: 10.1002/hon.2900070207. Hematol Oncol. 1989. PMID: 2784122

2

Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo.

Gill I, Agah R, Hu E, Mazumder A. Gill I, et al. Among authors: mazumder a. Cancer Res. 1989 Oct 1;49(19):5377-9. Cancer Res. 1989. PMID: 2788499

3

Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.

LeBerthon B, Khawli LA, Alauddin M, Miller GK, Charak BS, Mazumder A, Epstein AL. LeBerthon B, et al. Among authors: mazumder a. Cancer Res. 1991 May 15;51(10):2694-8. Cancer Res. 1991. PMID: 2021947

4

Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor.

Agah R, Malloy B, Sherrod A, Bean P, Girgis E, Mazumder A. Agah R, et al. Among authors: mazumder a. J Biol Response Mod. 1988 Apr;7(2):140-51. J Biol Response Mod. 1988. PMID: 3258905

5

Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia.

Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. Rarick MU, et al. Among authors: mazumder a. Am J Hematol. 1991 Dec;38(4):261-6. doi: 10.1002/ajh.2830380402. Am J Hematol. 1991. PMID: 1746533 Clinical Trial.

6

Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice.

Agah R, Malloy B, Sherrod A, Mazumder A. Agah R, et al. Among authors: mazumder a. Cancer Res. 1988 Apr 15;48(8):2245-8. Cancer Res. 1988. PMID: 3127048

7

Hemolytic anemia in a cancer patient treated with recombinant interferon-gamma.

Rabinowitz AP, Hu E, Watkins K, Mazumder A. Rabinowitz AP, et al. Among authors: mazumder a. J Biol Response Mod. 1990 Apr;9(2):256-9. J Biol Response Mod. 1990. PMID: 2111376

8

Interleukin-2 increases the antibody response in patients receiving autologous intralymphatic tumor cell vaccine immunotherapy.

Williams TW, Yanagimoto JM, Mazumder A, Wiseman CL. Williams TW, et al. Among authors: mazumder a. Mol Biother. 1992 Jun;4(2):66-9. Mol Biother. 1992. PMID: 1515096

9

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.

Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ, Belch A, Krishnan A, Vescio RA, Mateos MV, Mazumder A, Orlowski RZ, Sutherland HJ, Bladé J, Scott EC, Oriol A, Berdeja J, Gharibo M, Stevens DA, LeBlanc R, Sebag M, Callander N, Jakubowiak A, White D, de la Rubia J, Richardson PG, Lisby S, Feng H, Uhlar CM, Khan I, Ahmadi T, Voorhees PM. Lonial S, et al. Among authors: mazumder a. Lancet. 2016 Apr 9;387(10027):1551-1560. doi: 10.1016/S0140-6736(15)01120-4. Epub 2016 Jan 7. Lancet. 2016. PMID: 26778538 Clinical Trial.

10

Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.

Agah R, Malloy B, Kerner M, Mazumder A. Agah R, et al. Among authors: mazumder a. J Immunol. 1989 Nov 1;143(9):3093-9. J Immunol. 1989. PMID: 2809219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters